PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 118 filers reported holding PUMA BIOTECHNOLOGY INC in Q3 2021. The put-call ratio across all filers is 0.48 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $10,000 | -9.1% | 3,554 | 0.0% | 0.00% | – |
| Q4 2021 | $11,000 | -86.9% | 3,554 | -70.4% | 0.00% | – |
| Q3 2021 | $84,000 | +50.0% | 12,012 | +98.7% | 0.00% | – |
| Q2 2021 | $56,000 | -5.1% | 6,045 | 0.0% | 0.00% | – |
| Q1 2021 | $59,000 | -7.8% | 6,045 | -2.5% | 0.00% | – |
| Q4 2020 | $64,000 | +3.2% | 6,203 | 0.0% | 0.00% | – |
| Q3 2020 | $62,000 | -22.5% | 6,203 | -19.2% | 0.00% | – |
| Q2 2020 | $80,000 | +25.0% | 7,681 | +1.3% | 0.00% | – |
| Q1 2020 | $64,000 | -17.9% | 7,584 | -15.2% | 0.00% | – |
| Q4 2019 | $78,000 | -7.1% | 8,945 | +15.1% | 0.00% | – |
| Q3 2019 | $84,000 | -58.0% | 7,773 | -50.5% | 0.00% | – |
| Q2 2019 | $200,000 | -64.9% | 15,712 | +7.2% | 0.00% | – |
| Q1 2019 | $569,000 | +90.3% | 14,657 | 0.0% | 0.00% | – |
| Q4 2018 | $299,000 | -34.7% | 14,657 | +46.8% | 0.00% | – |
| Q3 2018 | $458,000 | -24.3% | 9,981 | -2.4% | 0.00% | – |
| Q2 2018 | $605,000 | -17.2% | 10,226 | -4.8% | 0.00% | -100.0% |
| Q1 2018 | $731,000 | -41.8% | 10,744 | -15.3% | 0.00% | 0.0% |
| Q4 2017 | $1,256,000 | -11.0% | 12,688 | +6.9% | 0.00% | 0.0% |
| Q3 2017 | $1,411,000 | +53.7% | 11,865 | +13.1% | 0.00% | 0.0% |
| Q2 2017 | $918,000 | +165.3% | 10,490 | +12.8% | 0.00% | – |
| Q1 2017 | $346,000 | +24.9% | 9,297 | +2.8% | 0.00% | – |
| Q4 2016 | $277,000 | -27.5% | 9,048 | +51.7% | 0.00% | – |
| Q3 2016 | $382,000 | +108.7% | 5,963 | -2.9% | 0.00% | – |
| Q2 2016 | $183,000 | +144.0% | 6,142 | +142.4% | 0.00% | – |
| Q1 2016 | $75,000 | -23.5% | 2,534 | +102.4% | 0.00% | – |
| Q4 2015 | $98,000 | -90.1% | 1,252 | -90.5% | 0.00% | -100.0% |
| Q3 2015 | $990,000 | +8.8% | 13,142 | +68.7% | 0.00% | 0.0% |
| Q2 2015 | $910,000 | -5.9% | 7,791 | +89.3% | 0.00% | 0.0% |
| Q1 2015 | $967,000 | +48.3% | 4,116 | +19.8% | 0.00% | 0.0% |
| Q4 2014 | $652,000 | -25.6% | 3,435 | -4.2% | 0.00% | 0.0% |
| Q3 2014 | $876,000 | – | 3,584 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Athyrium Capital Management, LP | 1,792,114 | $4,713,260 | 4.15% |
| Eversept Partners, LP | 1,681,149 | $4,421,422 | 0.37% |
| Camber Capital Management LP | 4,235,000 | $11,138 | 0.37% |
| Kynam Capital Management, LP | 473,975 | $1,246,554 | 0.20% |
| GLOBEFLEX CAPITAL L P | 538,559 | $1,416,410 | 0.17% |
| Affinity Asset Advisors, LLC | 202,349 | $532,178 | 0.15% |
| GSA CAPITAL PARTNERS LLP | 279,629 | $735 | 0.06% |
| RICE HALL JAMES & ASSOCIATES, LLC | 363,666 | $956,442 | 0.06% |
| Patriot Financial Group Insurance Agency, LLC | 67,000 | $176,210 | 0.04% |
| ACADIAN ASSET MANAGEMENT LLC | 1,858,000 | $4,884 | 0.02% |